Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial (J Neurol, (2014), 261, (2101-2111), 10.1007/s00415-014-7446-0)

Research output: Contribution to specialist publication › Corrections (errata and retractions) › peer-review

Contributors

  • Tjalf Ziemssen - , Department of Neurology (Author)
  • Ovidiu A. Bajenaru - , Carol Davila University of Medicine and Pharmacy (Author)
  • Adriana Carrá - , Hospital Británico de Buenos Aires (Author)
  • Nina de Klippel - , Virga Jessaziekenhuis (Author)
  • João Correia de Sá - , University of Lisbon (Author)
  • Astrid Edland - , Central Hospital of Buskerud (Author)
  • Jette L. Frederiksen - , University of Copenhagen (Author)
  • Olivier Heinzlef - , Hopital Tenon (Author)
  • Klimentini E. Karageorgiou - , General Hospital of Athens (Author)
  • Rafael H. Lander Delgado - (Author)
  • Anne Marie Landtblom - , Linköping University (Author)
  • Miguel A. Macías Islas - , Universidad de Guadalajara (Author)
  • Niall Tubridy - , Trinity College Dublin (Author)
  • Yossi Gilgun-Sherki - , Teva Pharmaceutical Industries Ltd. (Author)

Details

Original languageEnglish
Pages248
Number of pages1
Volume262
Issue number1
JournalJournal of neurology
Publication statusPublished - 1 Jan 2015
Peer-reviewedYes
No renderer: customAssociatesEventsRenderPortal,dk.atira.pure.api.shared.model.researchoutput.ContributionToPeriodical

Keywords

ASJC Scopus subject areas